FindTrial
Sign In

Improving Quality of Life in Dementia with Individualised Homoeopathic Medicines

The role of individualised homoeopathic medicines in improving the quality of life in dementia - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095340
Enrollment
40
Registered
2025-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F039- Unspecified dementia

Interventions

Intervention1: Individualized homoeopathic medicines: The individualised homoeopathic medicine will be prescribed with proper dose, potency (30C/200C/1M).follow up will be taken once in a month and ho

Sponsors

WHITE MEMORIAL HOMOEO MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age of the patient above 45 years. Confirmed cases of dementia through Montreal Cognitive assessment. Patient having MoCA score above 10 to 25.

Exclusion criteria

Exclusion criteria: Patients having other neurological disorders like Alzheimer disease, Parkinsons disease. Patients having other psychiatric illness like, Bipolar disorder, Schizophrenia etc. Patients under allopathic medication such as anticholinergic and antipsychotic drugs Patients having serious systemic disorders.

Design outcomes

Primary

MeasureTime frame
Quality of life will be assessed by using Dementia Quality of Life. Maximum score- 112 From baseline score: 1 to 9 score increases - Mild improvement. 10 19 score increases - Moderate improvement. More than 20 score increases - Marked improvementTimepoint: 3 months—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDR PRIYA RAJINI RM

WHITE MEMORIAL HOMOEO MEDICAL COLLEGE AND HOSPITAL

drpriyarm@gmail.com7598188279

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026